Total Payments
$21,979
2024 Payments
$2,555
Companies
60
Transactions
1,249
Medicare Patients
2,349
Medicare Billing
$303,749
Payment Breakdown by Category
Food & Beverage$19,736 (89.8%)
Other$1,973 (9.0%)
Education$270.55 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,736 | 1,242 | 89.8% |
| Honoraria | $1,500 | 1 | 6.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $400.00 | 1 | 1.8% |
| Education | $270.55 | 4 | 1.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $73.10 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,718 | 155 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,645 | 205 | $0 (2024) |
| QOL Medical, LLC | $1,881 | 117 | $0 (2024) |
| Janssen Biotech, Inc. | $1,677 | 88 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $1,542 | 3 | $0 (2024) |
| Celgene Corporation | $1,051 | 78 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $919.88 | 47 | $0 (2017) |
| Gilead Sciences, Inc. | $850.00 | 43 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $719.61 | 39 | $0 (2024) |
| Boston Scientific Corporation | $614.11 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,555 | 130 | Janssen Biotech, Inc. ($326.84) |
| 2023 | $3,197 | 203 | Celgene Corporation ($467.02) |
| 2022 | $2,585 | 155 | ABBVIE INC. ($455.29) |
| 2021 | $4,175 | 190 | Pharmacosmos Therapeutics Inc. ($1,500) |
| 2020 | $2,232 | 113 | QOL Medical, LLC ($538.91) |
| 2019 | $2,253 | 165 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($637.22) |
| 2018 | $2,544 | 160 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($717.16) |
| 2017 | $2,438 | 133 | Valeant Pharmaceuticals North America LLC ($919.88) |
All Payment Transactions
1,249 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: ONCOLOGY | ||||||
| 12/20/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: LIVER DISEASE | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $14.76 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $5.54 | General |
| Category: GI | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Immunology | ||||||
| 12/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $14.34 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/01/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $15.66 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/24/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $32.92 | General |
| Category: GI | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/19/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $10.70 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 570 | 654 | $425,659 | $77,365 |
| 2022 | 11 | 571 | 651 | $413,248 | $74,528 |
| 2021 | 16 | 655 | 774 | $460,433 | $88,648 |
| 2020 | 14 | 553 | 722 | $327,360 | $63,207 |
Total Patients
2,349
Total Services
2,801
Medicare Billing
$303,749
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 197 | 256 | $89,088 | $25,019 | 28.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 87 | 87 | $124,062 | $20,553 | 16.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $34,688 | $8,457 | 24.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 59 | 60 | $69,344 | $4,767 | 6.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 20 | 20 | $21,312 | $4,148 | 19.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 52 | $12,324 | $3,585 | 29.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 31 | 31 | $46,186 | $3,520 | 7.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $13,962 | $3,419 | 24.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $8,190 | $2,059 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $3,318 | $1,089 | 32.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $3,185 | $749.40 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 184 | 228 | $79,344 | $22,747 | 28.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 77 | 77 | $109,802 | $17,451 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $26,016 | $6,864 | 26.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 66 | 67 | $75,308 | $5,424 | 7.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 58 | 58 | $20,764 | $4,608 | 22.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 68 | $16,116 | $4,127 | 25.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $12,285 | $3,187 | 25.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 15 | 15 | $15,870 | $3,146 | 19.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 29 | 29 | $38,947 | $2,893 | 7.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 13 | 13 | $13,819 | $2,747 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 21 | $4,977 | $1,335 | 26.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 184 | 251 | $87,348 | $25,921 | 29.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 79 | 82 | $116,932 | $18,999 | 16.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 56 | 56 | $30,352 | $7,664 | 25.3% |
About Dr. Seth Rosen, MD
Dr. Seth Rosen, MD is a Gastroenterology healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457389983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Seth Rosen, MD has received a total of $21,979 in payments from pharmaceutical and medical device companies, with $2,555 received in 2024. These payments were reported across 1,249 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($19,736).
As a Medicare-enrolled provider, Rosen has provided services to 2,349 Medicare beneficiaries, totaling 2,801 services with total Medicare billing of $303,749. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Miami, FL
- Active Since 06/30/2006
- Last Updated 07/07/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1457389983
Products in Payments
- XIFAXAN (Drug) $1,844
- STELARA (Biological) $1,763
- Monoferric (Drug) $1,500
- Sucraid (Drug) $1,241
- ZEPOSIA (Drug) $983.39
- DUPIXENT (Biological) $814.05
- LINZESS (Drug) $783.80
- SUCRAID (Drug) $639.83
- INJECTAFER (Drug) $504.64
- Linzess (Drug) $503.34
- MOVIPREP (Drug) $498.89
- OCALIVA (Drug) $498.41
- IBSRELA (Drug) $483.18
- SKYRIZI (Biological) $414.50
- RINVOQ (Biological) $388.17
- ZENPEP (Drug) $347.26
- HUMIRA (Biological) $318.32
- DIFICID (Drug) $315.22
- XIFAXANIBSD (Drug) $308.42
- RELISTOR (Drug) $304.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Miami
Dr. Jerry Martel, M.d., M.p.h, M.D., M.P.H
Gastroenterology — Payments: $454,127
Gastroenterology $454,127
Andres Gelrud, M.d, M.D
Gastroenterology — Payments: $381,307
Gastroenterology $381,307
George Sanchez, Md, MD
Gastroenterology — Payments: $122,469
Gastroenterology $122,469
Jodie Barkin, M.d, M.D
Gastroenterology — Payments: $119,372
Gastroenterology $119,372
Sunil Amin, Md, MD
Gastroenterology — Payments: $102,696
Gastroenterology $102,696
Dr. Cynthia Levy, Md, MD
Gastroenterology — Payments: $97,416
Gastroenterology $97,416